| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |